This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Rapid Coagulation Testing Market

Market Insights on Rapid Coagulation Testing covering sales outlook, demand forecast & up-to-date key trends

Rapid Coagulation Testing Market By Product Type (Instruments, Coagulation Analyzers, Cartridges, Accessories and Disposables, Calibrators and Controls, Reagents), Method Type (Aggregometric, Viscoelastic) & Region - Forecast 2022-2032

Rapid Coagulation Testing Market Overview

The global rapid coagulation testing market size is set to reach US$ 8.6 Billion in 2032 and exhibit growth at an astonishing CAGR of 4.5% in the forecast period from 2022 to 2032. It is anticipated to be valued at US$ 3.7 Billion in 2022. The emergence of smartphone-based blood coagulation tests in developed countries is projected to propel the demand for rapid coagulation testing devices in future years.

Report Attribute

Details

Rapid Coagulation Testing Market Estimated Base Year Value (2021)

US$ 2.1 Billion

Rapid Coagulation Testing Market Expected Market Value (2022)

US$ 3.7 Billion

Rapid Coagulation Testing Market Anticipated Forecast Value (2032)

US$ 8.6 Billion

Rapid Coagulation Testing Market Projected Growth Rate (2022-2032)

4.5% CAGR

Rapid coagulation testing is referred to as the rapid specific testing of blood fluids at an individual’s bedside. The extensive usage of these tests for the management of perioperative coagulation is estimated to drive the growth in this market.

These help in reducing inappropriate transfusion and provide results in minutes. Two methods, namely, viscoelastic and aggregometry are mainly deployed for this type of testing.

Viscoelastic rapid coagulation methods are used to find detailed information about every aspect of coagulation, such as plasma and cellular components of whole blood. The aggregometry rapid coagulation method, on the other hand, is employed to analyze and monitor whole blood.

The ongoing development of personalized medicine and the urgent need to manage bleeding patients are expected to aid the growth in this market. In addition to that, the surging prevalence of cancer among the geriatric population is likely to fuel the growth.

Which are Some Prominent Drivers Spearheading Rapid Coagulation Testing Market Growth?

The surging demand for coagulation laboratory and special hematology is estimated to augment the rapid coagulation testing market growth in the evaluation period. The ongoing development of various advanced technologies, such as photoacoustic detection, electrochemical sensing, microfluidics, and fluorescent microscopy is also expected to bode well for the market.

These technologies are likely to be utilized for the development of highly robust and cost-effective Point-of-Care (POC) devices. The ability of these devices to measure electrochemical, mechanical, and optical parameters of clotting blood is anticipated to fuel the market. Also, the increasing prevalence of chronic blood diseases and cardiovascular issues is another vital factor that is set to drive the market.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Challenges Faced by the Rapid Coagulation Testing Industry?

Non-hematological staff members require competency and training to perform rapid coagulation tests. As compared to conventional testing, rapid coagulation tests are more expensive. Besides, these measure coagulations under artificial conditions and quality assurance standards are difficult to institute outside the laboratory. Spurred by the aforementioned factors, sales of rapid coagulation testing devices may be hampered in the evaluation period.

Why is Europe Emerging as an Opportunistic Rapid Coagulation Testing Market?

Europe is expected to remain at the forefront by generating the largest rapid coagulation testing market share in the assessment period. This growth is mainly attributable to the increasing technological advancement in the healthcare sector, especially in the U.K. and Germany.

The surging death rates due to strokes and ischaemic heart disease in Eastern and central Europe are likely to accelerate the need for rapid coagulation testing devices in future years. Increasing expenditure in healthcare and the availability of cutting-edge medical equipment across Europe are a couple of other factors that are set to spur the market.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How is Asia Pacific Contributing to Growth of the Rapid Coagulation Testing Market?

The increasing adoption of sedentary lifestyles and the rising demand for foreign investments in China and India are anticipated to bolster the Asia Pacific rapid coagulation testing market growth in the forthcoming years. The surging number of road accidents in these countries are expected to lead to the occurrence of harmful injuries, such as head trauma and blood clots. These are further likely to propel the need for rapid coagulation testing across Asia Pacific.

According to the India Brand Equity Foundation (IBEF), FDI inflows for the pharmaceuticals and drugs sector stood at US$ 18.12 billion between April 2000 and June 2021. The central government also established 638 e-hospitals across India to accelerate its ‘Digital India’ initiative. Thus, rising government spending on the development of healthcare infrastructure is projected to push the market in Asia Pacific.

Market Competition

Some of the renowned companies operating in the global rapid coagulation testing market include Entegrion, Inc., Abbott, Danaher, Medtronic, Siemens Healthcare Private Limited, F. Hoffmann-La Roche, Sysmex Corporation, Universal Biosensors, Helena Laboratories, Rapid Diagnostics Group of Companies, and Thermo Fisher Scientific among others.

Majority of the leading players in the market are striving to gain fast track approval from regulatory bodies, such as the U.S. FDA to market and distribute their products worldwide. A few other companies are aiming to diversify their existing portfolios by launching innovative products. Meanwhile, some of the local and start-up companies are engaging in acquisitions and partnerships to co-develop new products and cater to the ever-increasing demand from customers globally.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 4.5% from 2022 to 2032

Base Year for Estimation

2021

Historical Data

2015-2020

Forecast Period

2022-2032

Quantitative Units

Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Product Type
  • Method Type
  • End User
  • Region

Regions Covered

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • Middle East and Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Argentina
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • Nordics
  • BENELUX
  • Australia & New Zealand
  • China
  • India
  • ASEAN
  • GCC
  • South Africa

Key Companies Profiled

  • Entegrion, Inc.
  • Abbott
  • Danaher
  • Medtronic
  • Siemens Healthcare Private Limited
  • F. Hoffmann-La Roche
  • Sysmex Corporation
  • Universal Biosensors
  • Helena Laboratories
  • Rapid Diagnostics Group of Companies
  • Thermo Fisher Scientific

Customization

Available Upon Request

Key Segments Profiled in the Rapid Coagulation Testing Industry Survey

Product Type:

  • Instruments
  • Coagulation Analyzers
  • Cartridges
  • Accessories and Disposables
  • Calibrators and Controls
  • Reagents

By Method Type:

  • Aggregometric
  • Viscoelastic

By End User:

  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Home Care Settings

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • Middle East and Africa

Frequently Asked Questions

The global rapid coagulation testing market is expected to surpass US$ 8.6 Billion in 2032.

Europe is likely to lead the rapid coagulation testing market in the forecast period.

Entegrion, Inc., Abbott, Danaher, Medtronic, Siemens Healthcare Private Limited, F. Hoffmann-La Roche, and Sysmex Corporation are some of the renowned companies in the rapid coagulation testing market.

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Rapid Coagulation Testing Market